For years, scientists believed that assembling an infectious Zika virus in human cells required two key components: a specific viral protein in its entirety and a human enzyme that ensured viral maturity. This view guided much of the research into the virus's lifecycle and informed early drug design efforts.
New research now suggests that Zika virus can assemble without that protein segment, which was long considered essential. The finding indicates that the viral assembly process is more flexible than previously understood, and that the earlier model may have been incomplete.
While the source does not provide details on the exact protein or methods, the implication is clear: treatments targeting that segment alone may not be effective. Further studies will be needed to map the full assembly pathway and identify alternative targets for antiviral interventions.